S80775 |
Estramustine phosphate sodium |
源葉(MedMol) | 97% |
1mg | 5mg | 10mg | |
---|---|---|---|
1 mM | 1.772 ml | 8.86 ml | 17.72 ml |
5 mM | 0.354 ml | 1.772 ml | 3.544 ml |
10 mM | 0.177 ml | 0.886 ml | 1.772 ml |
50 mM | 0.035 ml | 0.177 ml | 0.354 ml |
- 提示:詳情請下載說明書。
- 產品描述: Estramustine phosphate sodium, an estradiol analog, is an orally active antimicrotubule chemotherapy agent. Estramustine phosphate sodium depolymerises microtubules by binding to microtubule associated proteins (MAPs) and/or to tubulin. Estramustine phosphate sodium can interfere mitosis, trigger cell death and induce apoptosis, which can be used for the research of cancer like prostate cancer
- 靶點: Microtubule/Tubulin;Apoptosis;Apoptosis;MicrotubuleAssociated
- 體內研究:
Estramustine phosphate sodium (Intraperitoneal injection, 4 or 12 mg/kg, a daily dose for 2 weeks) inhibits PAC120 tumor growth 53% by day 35
- 參考文獻:
1. C Wei, et al. Estramustine phosphate induces prostate cancer cell line PC3 apoptosis by down-regulating miR-31 levels. Eur Rev Med Pharmacol Sci. 2018 Jan;22(1):40-45. 2. Sonja S Mojsilovic, et al. Estramustine Phosphate Inhibits TGF- β-Induced Mouse Macrophage Migration and Urokinase-Type Plasminogen Activator Production. Anal Cell Pathol (Amst). 2018 Sep 2;2018:3134102. 3. Stephane Oudard, et al. Activity of docetaxel with or without estramustine phosphate versus mitoxantrone in androgen dependent and independent human prostate cancer xenografts. J Urol. 2003 May;169(5):1729-34.
- 溶解性: H2O : 62.5 mg/mL (110.75 mM; Need ultrasonic) DMSO : 5 mg/mL (8.86 mM; Need ultrasonic)
- 保存條件: 2-8℃
- 配置溶液濃度參考:
1mg 5mg 10mg 1 mM 1.772 ml 8.86 ml 17.72 ml 5 mM 0.354 ml 1.772 ml 3.544 ml 10 mM 0.177 ml 0.886 ml 1.772 ml 50 mM 0.035 ml 0.177 ml 0.354 ml
- 注意:部分產品我司僅能提供部分信息,我司不保證所提供信息的權威性,僅供客戶參考交流研究之用。
輸入產品批號:
本計算器可幫助您計算出特定溶液中溶質的質量、溶液濃度和體積之間的關系,公式為:
質量 (mg) = 濃度 (mM) x 體積 (mL) x 分子摩爾量 (g/mol)